REGISTER HERE FOR INVESTOR ALERTS

JOIN THE TPIV VIP LIST

By providing your e-mail address, you are consenting to receive press releases, presentations and other information concerning TapImmune. You may withdraw your consent at any time by using our unsubscribe feature.